#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic pulmonary fibrosis Infertility female Progressive multifocal leukoencephalopathy Crohn's disease B-cell lymphoma Transitional cell carcinoma Paraganglion neoplasm Postprandial hypoglycaemia Cystic fibrosis respiratory infection suppression Craniopharyngioma Craniocerebral injury Hereditary hypophosphataemic rickets Chronic graft versus host disease in skin Anaemia Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Proteus syndrome – Life with Disease Progressive multifocal leukoencephalopathy – Life with Disease Haemophagocytic lymphohistiocytosis – Treatment Mucopolysaccharidosis II – Basic Information Familial haemophagocytic lymphohistiocytosis – Trials in Disease Primary hyperoxaluria – Basic Information Netherton’s syndrome – Diagnostics IgA nephropathy – Life with Disease Pemphigoid – Diagnostics Sjogren’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Simvastatin Telmisartan 204-NETU Alizapride Danicamtiv Bulevirtide Azd8205 Mva-209-Fsp-B3 RUBIDIUM CHLORIDE Tenofovir Disoproxil Emiplacel Methotrexate Fingolimod Hydrochloride Ofloxacin Cetuximab Cefiderocol Sodium Acetate Trihydrate Doxorubicin Quinine Dihydrochloride Macrogol 3350 More therapies…

    Learn about Your Condition

    Double hit lymphoma Cutaneous sarcoidosis Rheumatoid arthritis Diabetes mellitus Pulmonary venous thrombosis Metastasis Metabolic syndrome Oesophageal adenocarcinoma Arrhythmia supraventricular Menopause Allergic respiratory disease Vitamin D deficiency Vascular malformation T-cell type acute leukaemia Dermatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal cell carcinoma stage IV

  • Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma stage IV
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Sunitinib
    • Ipilimumab
    • Nivolumab
    Austria Belgium Czechia Denmark Finland France +7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!